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ABSTRACT: Oleo-gum resins such as frankincense and myrrh are some of the economically and 
culturally valuable products obtained from trees and shrubs of the genera Boswellia and Commiphora, 
respectively. They are important natural plant products used in several industries that include 
pharmacology, food, flavour, liqueur and beverage, cosmetics, perfumery and others. Moreover, 
frankincense and myrrh have several local applications in medicinal, hygienic, and insecticide areas 
that could be developed through research. They are widely used in traditional medicines of several 
countries for treatments of a wide variety of ailments from embalming to cancer, leprosy, bronchitis, 
diarrhea, dysentery, typhoid, mouth ulcers, inflammatory complaints, viral hepatitis, female disorders, 
infections/wounds, coughs, tumour, and others. Although Ethiopia is one of the few countries that are 
endowed with large frankincense and myrrh resources, little proper exploitation of these resources has 
been made so far. In this paper a review is presented on pharmacological and industrial applications of 
these valuable resources. The information is expected to prompt the enormous economic opportunity 
that these resources could provide both at national and local levels. Concurrently, this opportunity, if 
properly exploited, will contribute significantly towards the conservation and management of the 
vegetation resources that yield frankincense and myrrh as well as their ecosystems. 
  





Ethiopia is well endowed with various species of 
Acacia, Boswellia and Commiphora that are known to 
produce economically valuable products, princi-
pally oleo-gum resins such as gum acacia, 
frankincense and myrrh. Particularly, the aromatic 
resinous plant exudates, frankincense and myrrh, 
have been treasured for their sacred and 
ceremonial uses since long, even before biblical 
times (Hillson, 1988). Above all, frankincense and 
myrrh have been employed for several millennia in 
a number of medicinal contexts (Grieve, 1979; 
Hillson, 1988; Bhatt et al., 1989; Michie and Cooper, 
1991; Thulin and Claeson, 1991), many of which 
hold true still today (Tariq et al., 1985; Thulin and 
Claeson, 1991; Yen, 1992; Shao et al., 1998; Huang et 
al., 2000). They are used for medicinal purposes in 
Europe, India, Africa, China and Middle East 
(Grieve, 1967; Grieve, 1979; Tariq et al., 1985; 
Michie and Cooper, 1991; Yen, 1992; Brown, 1995; 
Al-Harbi et al., 1997). Much in use from ancient 
times, frankincense and myrrh have continued to 
find modern pharmacological applications, most of 
them as predicted by the traditional therapies 
(Fratkin, 1986; Claeson et al., 1991; Michie and 
Cooper, 1991; Yen, 1992; Duwiejua et al., 1993; 
Safayhi et al., 1996; Al-Harbi et al., 1997; Shao et al., 
1998; Huang et al., 2000; Gupta et al., 2001; 
Massoud et al., 2001). 
Furthermore, frankincense and myrrh have 
been and still be used as raw materials in many 
industries such as perfumery, food, beverage as 
well as for religious rituals and several other local 
uses (Hall and Oser, 1965; Council of Europe, 1981; 
Tucker, 1986; Hillson, 1988; Ford et al., 1992; Farah, 
1994; FAO, 1995; Anonymous, 2001; Mulugeta 
Lemenih et al., 2003). Stiles (1988) emphasized that 
an even greater potential lies in developments to 
be made through research in the pharmaceutical, 
fragrance and flavour, food technology, epoxy 
resin/ plastics and coating industries to develop 
more products that would make use of these 
renewable resources. 
Although frankincense and myrrh constitute an 
integral part of the Ethiopia’s economy since 
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several millennia (Ahmed, 1982; Tucker, 1986; 
Thulin and Claeson, 1991; Farah, 1994; Kuchar, 
1995), little is known about their pharmacological 
and industrial uses in Ethiopia so far. 
Consequently, little use of them has been made in 
the country. We presume that lack of knowledge 
and information could be one possible reason for 
their under exploitations. Thus, a review is made 
in this paper on pharmacological and industrial 
uses of these valuable plant resources. The 
information can be used as an indicator of the rich 
potentials in the vegetation resources of the arid 
and semiarid lowlands of the country with the 
implication of the need to plan for extensive 




CHEMISTRY OF MYRRH AND 
FRANKINCENSE 
 
Both frankincense and myrrh are essentially 
mixtures of volatile oils, resin, gum and impurities. 




Myrrh is oleo-gum resin exudates obtained from 
several species in the genus Commiphora. It 
contains ca. 57–61% water-soluble gum, 7–17% 
volatile oils, and 25–40% alcohol-soluble resins and 
3–4% impurities (Karamalla, 1997; Massoud et al., 
2001). The alcohol-soluble resins of myrrh consist 
of commiphoric acids, commiphorinic acid, 
heeraboresene, heerabomyrrhols, and commiferin 
(Bradley, 1992; Leung and Foster, 1996; Newall et 
al., 1996; Rao et al., 2001). Furthermore, the resins 
were found to contain α-, β-, and γ-commiphoric 
acids, commiphorinic acid, α- and β-herrab-
omyyhols, heerboresene, commiferin, kerto-
steroids, compesterol, β-sitosterol, cholestrerol, α-
amyrone and 3-epi-α-amyrin (Rao et al., 2001). Two 
triterpenes have been identified in the resins of C. 
incisa and C. kua and their potential 
chemotaxonomic significance indicated (Provan 
and Waterman, 1986). 
The volatile oil fraction contains different 
terpenes, sesquiterpenes, esters, elemol, 
cinnamaldehyde, cuminaldehyde, cumicalcohol, 
eugenol, heerabolene, limonine, dipentene, pinene, 
m-cresol, cadinene and numereous furano-
sesquiterpenes (Rao et al., 2001), myrcene and α-
camphorarene; steroids including Z-guggulsterol, 
and I, II, III guggulsterol (Kapoor, 1990; Huang, 
1999), aldehydes and alcohols (Treas and Evans, 
1978). 
The water-soluble gum or mucilage fraction is 
composed mainly of acidic polysaccharide with 
galactose, xylose, 4-0-methyl-glucuronic acid and 
arabinose in a ratio of 8: 7: 2 with ca. 18–20% 
protein (Bradley, 1992; Wichtl and Bisset, 1994), 
and also on hydrolysis the gum yields arabinose, 
galactose, xylose and 4-0-mythylglucuronic acid 
(Leung, 1980; Evans, 1989). Characteristic 
constituents of myrrh are mainly terpenoids, 
including furanosensequiterpenoids with eudes-
mane, germacrane, elemane, or guaiane structures 
(Bradley, 1992; Witchtl and Bisset, 1994), wheras íts 
characteristic odor is due to the furanoses-
quiterpenes (Bruneton, 1995), which may also be 
the characteristic components of pharmaceutical 
myrrh (Wichtl and Bisset, 1994). 
Extraction of gum myrrh with 90% alcohol yield 
a crude polysaccharide (PS) in the ranged of 27%–
60% (Treas and Evan, 1978) while the crude PS of 
myrrh is found to contain 18% protein (Anderson 
et al., 1965). 
 
Frankincense 
Frankincense is oleo-gum resin obtained from 
several species of Boswellia trees. Frankincense is 
composed of about 5–9% essential oil, 65–85% 
alcohol-soluble resins, and the remaining water-
soluble gums (Tucker, 1986) or 8–9% essential oil, 
45–50% resin, 30–40% gum and 4–5% impurities 
(Murthy and Shiva, 1977). 
The oil portion contains 62.1% ester, 15.4% 
alcohol, 9.9% monoterpene hydrocarbons and 7.1% 
diterpenes (Wahab et al., 1987). About 27 
sesquiterpene hydrocarbons have been identified 
in the steam-distilled oils of Boswellia species (Yates 
and Wenninger, 1970). The oil materials have 
shown to contain α-pinene, α-thujene, β-pinene, 
camphene, myrcene, o-methylanisole, α-terpinene, 
methoxytoluene, hexyl acetate, limonene, 1, 8-
cineole, n-octanol, linalool, octyl acetate, bornyl 
acetate, cembrene A, incensole, incensole acetate, 
sabinene, o-cymene, ρ-cymene, 1,8-cineole, cis-β-
ocimene, trans-β-ocimene, ϒ-terpinene, 1-octanol, 
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terpinolene, linalool, 1-decanol, terpinen-4-ol, α-
terpineol, 1-octyl acetate, citronellyl acetate, neryl 
acetate, geranyl acetate, hexyl hexanoate, 1-decyl 
acetate, hexyl octanoate, α-campholenic aldehyde, 
caproic acid, oenanthic acid, caprylic acid, 
pelargonic acid, lauric acid, and verbenone 
(Tucker, 1986; Wahab et al., 1987). 
The gum portion was found to contain 2 
polysaccharides: I) composed of 1 galactose: 1 
arabinose and II) composed of 2 galactose: 1 
galacturonic acid (El-Khadem and Megahed, 1956). 
The terpenoid portion contains boswellic acids and 
albanoresin. The boswellic acids components are 
shown to be the active constituents in Boswellia for 
many of its medicinal uses (Safayhi et al., 1992; 
Ammon et al., 1993). Boswellic acids are further 
known to contain β-boswellic acid, acetyl-α-
boswellica acid, and acetyl-β-boswellic acid, and 
associated 3-acetyl-11-hrdroxy-β-boswellic acid 
and 11-keto-β-boswellic acid acetate chemicals 
(Corsano and Iavarone, 1964; Huang et al., 2000). 
Today, extracts for frankincense are typically 
standardized to contain 37.5–65% boswellic acids 
(Ammon et al., 1993). 
13C NMR analysis of crude steam distillation of 
frankincense from B. papryfera in Ethiopia 
indicated that the main component (88%) of the 
resin is octyl acetate, a result also confirmed by GC-
MS analysis supported by NIST and Wiley database 
(Ermias Dagne et al., 1997). The purified PS from B. 
papyrifera has 4–8 % protein (Anderson et al., 1965) 
while Abdel Kariem (1992) has recently reported 
that the protein content of crude PS of B. papyrifera 
is only 3.9%. 
 
 
PHARMACOLOGICAL USES OF FRANKIN-
CENSE AND MYRRH  
 
Uses in folk medicine 
The application of fragrant oleo-gum resins known 
as frankincense and myrrh for medicinal values is 
among man’s oldest therapies. The Papyrus Ebers 
of about 1500 B.C is perhaps the oldest list of 
prescriptionin which the priests who supervised 
funerals, mummification and cremations describe 
the value of both resins in each of these 
procedures, as well as in the treatment of wounds 
and skin sores (Michie and Cooper, 1991). 
Furthermore, until the beginning of the twentieth 
century, frankincense and myrrh were components 
of European pharmacopoeia, but they have since 
fallen into obscurity during the era of synthetic 
drugs (Krieglstein et al., 2001). Nevertheless, 
frankincense and myrrh are still widely used 
therapeutically in regions raging from North 
Africa to China (Krieglstein et al., 2001), and 
especially in the traditional Ayurvedic medicines 
of India, Arabia and China (Al-Harbi et al., 1994; 
Safayhi, et al., 1996; Shao et al., 1998; Krieglstein et 
al., 2001; Rao et al., 2001), as well as in Ethiopia and 
Somalia (Martinetz et al., 1989; Thulin and Claeson, 
1991; Farah, 1994; Claeson and Samuelsson, 1998; 
Mulugeta Lemenih et al., 2003). 
The oleo-gum resin of Commiphora myrrha Engl. 
locally called ‘mur’ or ‘myrrh’ is highly reputed 
and commonly used in Arab medicines for the 
treatments of some inflammatory conditions, as an 
antipyretic, anti-septic, stimulant, anti-infections, 
bronchial complaints; mouth wash and to cure 
different stomach problems including stomach 
cancer (Chopra et al., 1958; Tyler et al., 1981; 
Hartwell, 1982; Tariq et al., 1985; Angeel et al., 1987; 
Evans, 1989; Iwu, 1990; Brown, 1995; Rao et al., 
2001). Myrrh is also used in Arabia to cure tumors 
of the spleen, liver, stomach, breast, head, nose and 
eye (Angeel et al., 1987; Hartwell, 1982; Evans, 
1989). Today, crude myrrh is dispensed 
throughout eastern Africa and Saudi Arabia as an 
anti-inflammatory and anti-rheumatism drug 
(Iwu, 1990). 
Myrrh and frankincense have a long history of 
therapeutic use in Indian Ayurvedic system of 
medicine (Bhatt et al., 1989; Brown, 1995; Majeed et 
al., 1996; Huang et al., 2000). For instance, gum 
resin exudate of Boswellia serrata is used as a 
commercial herbal medicine (Majeed et al., 1996). 
Myrrh is used in India to treat mouth ulcers, 
gingivitis, pharyngitis, respiratory catarrh 
(Karnick, 1994), to treat rheumatoid arthritis, heart 
ailments, neurological disorders, skin infections, 
and obesity (Bhatt et al., 1989). Externally, it is used 
as an astringent topical application to ulcers and as 
a gargle for spongy gums (Nadkarni, 1976), as 
astringent demulcent, expectorant, alternatives, 
stomachache, carminative, aphrodisiac and 
antiseptic (Bhatt et al., 1989). As a treatment for 
stomatitis (inflammation of the mouth), it is 
combined with honey and rectified spirit, then 
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dissolved in rose petal infusion, and taken as a 
mouthwash. Myrrh tincture (mixture) is also used 
to treat many disorders associated with the female 
reproductive cycle, particularly dysmenorrhea and 
amenorrhea, and to help relieve some of the 
uncomfortable symptoms of menopause (Frawley 
and Lad, 1986; Nadkarni, 1976). Frankincense from 
Boswellia serrata is also widely used in India for 
several disease treatments, particularly 
inflammation bowl diseases (IBD) (Huang et al., 
2000; Gupta et al., 2001).  
Use of myrrh and frankincense was also 
introduced into both the Chinese and Tibetan 
systems of medicine sometime during the seventh 
century (Clifford, 1984; Brown, 1995; Leung and 
Foster, 1996), where they are popular today as 
herbal medicines (FAO, 1995). In Chinese medicine, 
myrrh from C. myrrha is used to treat impact 
injury, incised wounds, chest pains, sinew and 
bone pain, menstrual block, and hemorrhoids, 
among other conditions, as well as various topical 
plaster-adhesives and lotions, including die-da-
yao-jing (Traumatic Injury Medicine Essence) 
(Fratkin, 1986; Yen, 1992). Myrrh and frankincense 
are also used to treat leprosy, cancer, gonorrhea, 
carbuncles, bleeding disorders, wounds and as an 
astringent in China (Clifford, 1984; Brown, 1995; 
Leung and Foster, 1996). 
In Somalia and Ethiopia they are also used for 
the treatments of allergies, snake and insect bites, 
colds, coughs, diarrhea, headaches, syphilis, 
stomach complaints, back complaints, 
disinfections, purifications and hygiene, to correct 
female disorders during menopause and topically 
for the treatments of wounds in humans and 
livestock (Martinetz et al., 1989;Thulin and Claeson, 
1991; Farah, 1994; Claeson and Samuelsson, 1998; 
Mulugeta Lemenih et al., 2003). 
Myrrh has always had a wider medicinal 
application than frankincense (Michie and Cooper, 
1991; Farah, 1994). It is described in early Sumerian 
inscriptions detailing treatments for infected teeth 
and worms, while Hippocratic writings (4th 
century B.C.) contain some 54 references to myrrh 
out of 131 descriptions of the use of incenses: it was 
the most popular component of wounds, sepsis 
and worms (Michie and Copper, 1991). Moreover, 
myrrh’s antibiotic effect had been successfully 
utilized before the first century B.C to prevent the 
fermentation of wine to vinegar a central challenge 
of the technology of the day (Michie and Cooper, 
1991). Generally, myrrh has been used medicinally 
as an embalming agent, anti-infection, anti-skin 
inflammation, painkiller, anti-sores, to treat worm 
infestation, coughs, as a cure for cancer, leprosy, 
and syphilis since ancient times (Dörr, 1973; 
Groom, 1981; Brown, 1995; Archaeology, 1996). It 
has been also used to treat herpes (Nadkarni, 
1976). It is used as an anti-infection, anti-
inflammatory, antiseptic, astringent and as a tonic, 
as a powerful infection fighter, and an effective 
expectorant (Grieve, 1979). 
 
Pharmacological uses 
Several folklore claims about natural drugs have 
continued to be verified on modern scientific 
grounds. Similarly, both frankincense and myrrh 
have found modern pharmacological applications 
for several disease treatments most of them as 
predicted by the traditional therapies. Particularly, 
their unique chemical compositions, pharma-
cological activities and non-toxicity tend to support 
the safe use of these popular traditional drugs in 
modern therapies (Michie and Cooper, 1991). 
Recently, two compounds of myrrh, 
furanoeudesma-1, 3-diene and curzarene, are 
reported to have indeed pronounced pain relieving 
(analgesic) properties as claimed by traditional 
therapies (Archaeology, 1996). The anti-inflamma-
tory, antipyretic and antihistaminic effects of 
Commiphora myrrha (Tariq et al., 1985), 
hypolipidemic (Malhotra et al., 1977), hypocholes-
teremic, antiartheroscerotic (Lata et al., 1991), 
antiarthritic potential (Duwiejua et al., 1993), 
antigastric ulcer and cytoprotective effect (Al-
Harbi et al., 1997), anti-tumour potential (Queshi et 
al., 1993; Al-Harbi et al., 1994), smooth muscle 
relaxing effect of C. guidottii (Claeson et al., 1991), 
anti-inflammatory effect of C. mukul and C. incisa 
(Duwiejua et al., 1993), antiulcer effect (Al-Harbi et 
al., 1997); anti-schistosomiasis (Massoud et al., 
1998), anti-fascioliasis (Massoud et al., 2001), 
reduction of cholesterol and triglycerides (Michie 
and Cooper, 1991), hypolipidemic (Malhotra et al., 
1977), hypocholesteremic and antiartherosclerotic 
(Lata et al., 1991), pediatric and blood lipid 
remedies in Children (Michie and Cooper, 1991), 
and without toxicity side effects (Rao et al., 2001; 
Massoud et al., 2001) were verified. Myrrh also has 
astringent properties and has a soothing effect on 
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inflamed tissues in the mouth and throat. Studies 
continue on the potential anticancer actions of 
myrrh resin (Al-Harbi et al., 1994; Dolara et al., 
1996). In addition to its antiseptic and expectorant 
abilities, myrrh destroys putrefaction in the 
intestines and prevents the absorption of toxins in 
the blood; it stimulates blood flow to the capillaries 
and promotes menstruation (Nadkarni, 1976; 
Frawley and Lad, 1986). 
The resinous portion of myrrh/guggal carries 
significant anti-inflammatory, antirheumatic and 
hypocholesterolemic/hypolipaemic activity. It is 
also known for a rich source of steroids, which 
may find use as an alternative raw material for the 
synthesis of important corticosteroid drugs such as 
dexamethasone and betamethasone (Bhatt et al., 
1989). For instance, a preparation by name ‘Guglip’ 
developed from guggal (gum resin from 
Commiphora wightii) by the Central Drug Research 
Institute, Lucknow in India is reported to possess 
hypolipiemic activity equivalent to that of 
clofibrate (ethyl p-chlorophenoxyisobutyrate)-the 
present drug of choice (Bhatt et al., 1989). As 
Clofibrate is being discontinued and phased out in 
the USA on account of its toxic manifestations, there 
is ample scope for introducing guglip on a 
commercial scale (Bhatt et al., 1989). 
In Chinese medicine, myrrh from C. myyrha (syn 
C. molmol) is used as a component in many patent 
medicines, including bu-gu-zhi-wan (Psoralea 
Pills) and zhi-wan (Hemorrhoid Pills), as well as 
various topical plaster-adhesives and lotions, 
including die-da-yao-jing (Traumatic Injury 
Medicine Essence) (Fratkin, 1986; Yen, 1992). 
In Germany, myrrh gum-resin and myrrh 
tincture are both official in the German 
Pharmacopeia, approved in the Commission E 
monographs, and the tincture dosage form is 
official in the German Standard License 
monograph (Wichtl and Bisset, 1994; Deutsches 
Arzneibuch (DAB), 1997). The tincture is used as a 
mono-preparation and also as a component of 
various dental remedies and mouthwashes, 
toothpaste, ointments, paints, and coated tablets, 
where the applications by paint, gargle, and/or 
rinse are used in dentistry (Wichtl and Bisset, 
1994). For example, the product Merfluan® is an 
effervescent dentifrice salt with myrrh (Mielck, 
1970). Pediatric medicine, tincture of myrrh is used 
in Germany to treat oral condidiasis (thrush), 
which is common in infants (Schilcher, 1997). 
In the United States, myrrh was formerly official 
in the United States Pharmacopeia and National 
Formulary (Leung and Foster, 1996). It was used as 
an aromatic astringent mouthwash (Taber, 1962). 
Myrrh’s constituents include aldehydes and 
phenols, which stimulate drying and cleansing 
actions through topical administration. As a salve, 
myrrh is used to treat hermorrhoids, wounds, and 
bedsores. In tincture form, gargles and 
mouthwashes are considered useful in treating 
sore throats or other oral mucosal or gingival 
irritations (Tyler, 1993). 
The British Herbal Pharmacopoeia (BHP) 
reported antiseptic action of myrrh (BHP, 1996). The 
Merck Index reported its therapeutic action as 
carminative and astringent (Budavari, 1996). 
Myrrh has also shown to have disinfecting, 
deodorizing, and granulation-promoting 
properties (Wichtl and Bisset, 1994). The British 
Herbal Compendium indicates the use of myrrh 
tincture as a gargle to treat pharyngitis and 
tonsillitis (Bradley, 1992). In France, its topical use 
is approved for the treatment of small wounds, for 
nasal congestion from the common cold, and for 
local application as an anodyne to treat affections 
of the buccal cavity and the oropharynx (Bradley, 
1992; Bruneton, 1995). 
The approved modern therapeutic applications 
for myrrh are based on its long history of use in 
well established systems of traditional and 
conventional medicine, case studies, in vitro 
studies, pharmacological studies in animals, and 
on phytochemical studies of its volatile oil, gum 
and resin fractions (Blumenthal et al., 1998). 
Frankincense has also been employed for 
medicinal purposes since antiquity. In all human 
civilizations (Egyptians, Greeks, Romans, Chinese, 
Arabs, Indians, etc.) it was used as anti-catarrhal, 
anti-depressant, anti-intiseptic, anti-tumoral, 
diuretic stimulant, emmenagogue, for treatment of 
cough and asthma, as expectorant, immune 
stimulant, and sedative (Wahab et al., 1987; Gore 
enterprises (1999). In today’s world as well, it is 
used for asthma, ulcers, aging, allergies, snake and 
insect bites, bronchitis, cancer, carbuncles, catarrh, 
colds, coughs, diarrhea, diohtheria, headaches, 
healing, hemorrhaging, herps, high blood pressure, 
inflammation jaundice, laryngitis, meningitis, 
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nervousness, prostate, pneumonia, respiratory 
problems, scarring sciatic pain, soars, spiritual 
awareness, staph, strep, stress, syphilis, T.B., 
tension, typhoid, wounds, warts and to strengthen 
the immune system (Leung and Foster, 1996). 
Pharmacological applications recently justified 
that frankincense can be used as anti-tumor and 
anti-carcinogenic (Huang et al., 2000), anti-
inflammatory activity (Shao et al., 1998; Safayhi et 
al., 2000; Krieglstein et al., 2001), anti-proliferative 
effects (Glaser et al., 1999; Hoernlein et al., 1999), 
anti-chronic colitis (Gupta et al., 2001), anti-
bronchial asthma (Gupta et al., 1998;  Safayhi et al., 
2000), anti-human leukemia HL-60 cells and the 
DNA, RNA and protein synthesis in HL-60 cells 
(Shao et al., 1998). Controlled, double blind studies 
have shown that Boswellia extracts are very helpful 
for ulcerative colitis (Singh and Atal, 1986). The 
anti-inflammatory effects of treatment with 
Boswellia extract or AKBA (Acetyl-11-keto-β-
boswellic acid) in experimental ileitis in rats are 
comparable to those achieved by treatments with 
standard drugs of Inflammatory Bowls Disease 
(IBD) such as prednisolone and sulfasalazin 
(Yamada et al., 1993), and pilot study in human 
ulcerative colitis of the same procedure reported 
fewer side effects of treatment with Boswellia 
extract than with steroids (Gupta et al., 1997). 
Boswellia extracts inhibits pro-inflammatory 
mediators in the body, such as leukotrienes (Singh 
and Atal, 1986), and as opposed to NSAIDS, long-
term use of boswellia extracts (crude) does not lead 







The chemistry of frankincense and myrrh is 
already described above. The three main 
constituents of myrrh: the resin, the gum, and the 
volatile oil are all important in myrrh’s activity as a 
herbal medicine. The crude resin was shown to 
have anti-inflammatory activity (Duwiejua et al., 
1993), a combination of resin and volatile oil in the 
ration of 8: 3.5 was indicated effective to treat 
fascioliasis (Massoud et al., 2001), petroleum ether 
extract of myrrh was also found effective as anti-
inflammatory activity (Tariq et al., 1985), T-Cadinol 
of the volatile oil component was known to have 
muscle relaxing effect (Claeson et al., 1991), the 
aqueous suspension of myrrh was found effective 
as anti-ulcer and cytoprotective (Al-Harbi et al., 
1997). The resin has shown to kill various microbes 
and to stimulate macrophages (a type of white 
blood cell) (Mills, 1991). 
Myrrh has been shown to work in two 
complementary ways. Primarily it stimulates the 
production of white blood corpuscles (with their 
anti-pathogenic actions) and secondarily it has a 
direct anti-microbial effect (Sharma and Sharma, 
1969; Tariq et al., 1977; Satyavati et al., 1988; 
Malhotra and Ahuja, 1991; Mills, 1991).  
 
Frankincense 
Frankincense consists of essential oils, gum, and 
terpenoids. The boswellic acids in the terpenoid 
portion are the active constituents in Boswellia 
(Safayhi et al., 1996). Studies have shown that the 
boswellic acids have an anti-inflammatory action 
(Safayhi et al., 1992)-much like the conventional 
non-steroidal anti-inflammatory drugs (NSAIDS) 
used for inflammatory conditions. Furthermore, 
among the constituents of boswellic acid, β-
boswellic acids (the major constituents of boswellic 
acids) was shown to have anti-inflammatory and 
anti-arthritic pain activity, which was found to be 
due to their ability to inhibit 5-lipoxygenase 
activity (Safayhi et al., 1992; Ammon et al., 1993; 
Majeed et al., 1996). AKBA components of the 
boswellic acids are also identified to be among the 
biologically active and most potent constituents 
(Krieglstein et al., 2001). 
 
 
INDUSTRIAL AND LOCAL USES OF  
FRANKINCENSE AND MYRRH 
 
Industrial uses 
Myrrh and frankincense are widely used today in 
several industries such as food, beverages, 
perfumes, pharmacology, insecticides, and others. 
 
Perfumery 
Both myrrh and frankincense are highly valued 
for their aromatic fragrances and are common 
ingredients in incense, perfume and potpourris, 
soaps, detergents, creams and lotions, and are 
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often included in meditation blends, as it 
strengthens the psyche and aids in deepening the 
meditative state (FAO, 1995; Leung, 1980). The 
Flavour Extract Manufacturer’s Association (FEMA) 
has given them general recognition as safe (GRAS) 
status as a flavor ingredient (NO. 2765) (Hall and 
Oser, 1965; Leung, 1980; Fragrance Foundation, 
1983; Ford et al., 1992). 
Frankincense is a favoured ingredient in 
potpourris, as it is known to hold its fragrance for a 
very long time, some even say indefinitely (Tucker, 
1986). Besides adding a special fragrance to any 
blend, it is also noted to have some value as a 
fixative in perfumes and potpourris. It is employed 
by perfumers as an absolute (by -alcohol 
extraction), oil, or resinoid (by hydrocarbon 
extraction) and is used in the Oriental bases, 
ambers, powder perfumes, floral perfumes, citrus 
colognes, spice blends, violet perfumes, male 
fragrances, soaps, lotions, creams, etc. (Leung, 
1980; Tucker, 1986; FAO, 1995). It is also used in the 
formulation of many modern perfumes, including: 
Replique by Colonia, Me! by Frances Denney, 
Mennen Millionaire by Mennen, Nino Cerruti Pour 
Homme by Uniperf, Onna by Gary Farn, Sculpatura 
by Jovan, etc. (Tucker, 1986). 
Over 2000 years ago, myrrh was one of the most 
desired, highly valued and most sought after items 
in the world (Wilford, 1997). It has been used 
during these times for incense, perfume and 
medicinal purposes. Myrrh was mentioned 22 
times in Bible, as a gift, incense or as article of 
merchandise (Tucker, 1986). Myrrh is familiar to 
many religions as it is used for incense in religious 
rituals, and is mentioned and used in the Jewish, 
Christian, and Muslim holy texts (Grieve, 1979; 
Tucker, 1986). 
The odor of myrrh is described as warm-
balsamic, sweet, and somewhat spicy-aromatic, 
sharp and pungent when fresh, thus has been 
employed by perfumers as an absolute, oil, or 
resinoid, and is used in Oriental-spicy bases, 
chypres, woody bases, forest notes, pine 
fragrances, etc. (Tucker, 1986). Myrrh is also 
included in the formulation of a number of 
modern perfumes, including: Fidji by Guy Laroche, 
Onna by Gay Farn, Volcan d’Amour by Diane von 
Furstenburg, etc, (Fragrance Foundation, 1983). 
The resinoids are also used in soaps and detergent; 
and among the user are the multinationals such as 
Unilever and Proctor & Gamble (Farah, 1994). 
Synthetic products as ingredients of perfumery 
and other cosmetics stand as major competitors for 
the derivatives of the natural gums. They are the 
advantage of being cheap, steady supply, 
predictable olfactory and chemical properties and 
immune to supply and quality problems facing the 
natural products (Farah, 1994; Krieglstein et al., 
2001). Nevertheless, natural ingredients will 
probably continue to be used, as certain elements 
are difficult to reproduce exactly by synthetic 
substitutes. 
 
Food and beverages 
Frankincense and myrrh products have also 
wide ranges of other industrial uses in areas such 
as food industry, beverages, candies, chewing 
gums, confectioneries, gelatins, nut products, 
puddings and canned vegetables (FAO, 1995). The 
U.S. Food and Drug Administration also approved 
myrrh for food use (21 Code of Federal 
Registration-CFR 172.510), while the Council of 
Europe included myrrh in the list of plants and 
parts thereof that are acceptable for use in foods 
(Ford et al, 1992; Council of Europe, 1981). Typical 
applications include: adhesive thickeners, 
thickeners, stabilizers, flavour, fixatives and 
emulsifying agents in food products, clarification 
in beverages, and release agents for rubber 
products. In the Middle East, particularly Saudi 
Arabia, approximately 500 tonnes of Somali type 
olibanum are imported for chewing gum 
manufacturing, while similar quantity are also 




Myrrh is also used as an insecticide especially as 
a repellent of termites and as a mosquito repellent 
when blended as incense sticks (Farah, 1994). 
Essential oil from B. serrata is found to affect 
spermatogenesis in dysdercu similes, thereby acting 
as an effective insect growth regulator (Karamalla, 
1997). Constituent of the resin from C. rostrata have 
repellent effects against the maize weevile, while 
the effect of gum resin of B. papyrifera and C. 
africana on three insect pests of economic 
importance, has led to morphological 
malformation of adults and pupa, reducing the 
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emergence of adults and increasing mortality rate 
(Karamalla, 1997). 
 
Other industrial uses 
The liquid part of freshly collected boswellia oil, 
is very similar to turpentine oil obtained from 
Pinus spp., and readily dissolves colophony, 
dammar and other resins (Murthy and Shiva, 
1977). The higher iodine number of the volatile oil 
that consists mainly dextropinene mixed with L-
pinene of boswellia gum-resin indicates its 
suitability for paint and varnish industry, and can 








The mysterious appeal incense has had throughout 
human history and with which it is still connected 
seems to derive primarily from its ritual 
importance in divine worship: that is why when 
people think of frankincense/myrrh they 
immediately think of the "incense" part (Farah, 
1994). Earliest records of frankincense and myrrh 
list applications both as incense and medicine 
(Michie and Cooper, 1991). The ancient Egyptians, 
Babylonians, Assyrians and Jewish and latter the 
Orthodox and Roman Catholic Christians used 
them for fragrance in their religious rituals. Still 
today Orthodox and Roman Catholic Churches in 
Europe and Latine America use approximately 500 
tonnes of Eriterean-type Olibanum every year as 
incense (FAO, 1995). Similarly an estimated 
quantity of 2050 tonnes of frankincense are 
consumed every year by the Ethiopian Orthodox 
Church, while the quantity of 440 tonnes are used 
for various ritual and domicile purposes in Addis 
Ababa alone (Tilahun Gebremedhin, 1997). 
Besides, in many countries such as Greek and 
Roman they were used as incense in everyday life 
burning on the braziers that provided heat in the 
domicile. In ancient Egyptian, they were used for 
purification of cities (Groom, 1981). 
 
Hygienic and other uses 
Many local uses, which may have potential 
industrial significance, can be attached to the 
fragrance as well as the medicinal values of both 
frankincense and myrrh. Domestic fumigation is 
very common around the horn of Africa in 
Ethiopia, Somalia, Eritrea, Yemen and Djibouti. 
The burning of incense in these countries, include: 
sanitation/hygienic, purification and charismatic 
purposes. Burning creates pleasant smell while 
dispelling bad smells, keeps away insects such as 
flies, mosquitoes and bees in restaurants. Incense 
burning is a companion of many ceremonies such 
as coffee making in traditional style, chat chewing 
and other ceremonies. In local areas where the 
gum and resins are produced smoking with 
incense is used to disinfect and dye water and milk 
vessels (Farah, 1994). 
The most widely acknowledged local uses of 
frankincense and myrrh are probably their 
medicinal values (Kuchar, 1995). They have been 
used for several diseases (internal) and wound 
treatments by topical application both for human 
and domestic animals (Farah, 1994; Kuchar, 1995; 
Mulugeta Lemenih et al., 2003). Internally, they 
have been used to treat stomachache, snakebites, 
venereal complaints, chronic cough, polio, tumor, 
disorders in women, tumor, diarrhea, chest 
congestion, and back complaints (Claeson et al., 
1991; Farah, 1994; Mulugeta Lemenih et al., 2003). 
Some frankincense types are chewed to refresh 
breath, and protect teeth and strengthen gums 
(Farah, 1994). Myrrh is usually more valuable for 
local medicine than frankincense (Farah, 1994). 
 
Uses as famine food 
Many Boswellia, Commiphora and Acacia species 
also supply wild foods that are used as emergency 
or famine foods in several places. This is extremely 
important for arid lowlands characterized by 
frequent droughts and consequently fodder, crop 
and livestock failures as are often the case in the 
arid lowlands of Ethiopia. Some Boswellia and 
Commiphora species used for emergency food in 
different countries as well as parts used are 
summarized in Table 1. 
 
Table 1. Some Commiphora and Boswellia species known to be used as emergency food. 
 
Species Part used  Country 
Commiphora spp Leaves  Kenya (Mbeere division, Embu district) 
Commiphora africana  Unspecified Nigeria (Kano State, northern) 
Commiphora cærula  Yyoung roots chewed for juices Central Tanzania 
Commiphora neglecta Leaves and roots eaten Kenya (Mbeere division, Embu district) 
Commiphora spp. Young twig chewed for juice/water Ethiopia (Liban zone, ESNRS) 
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IMPLICATION FOR THE MANAGEMENT OF 
THE VEGETATION 
 
Frankincense and myrrh have been indicated to 
have wide pharmacological and industrial 
potentials. This indicates that the vast vegetation 
resources rich in Boswellia and Commiphora species 
in the dry lowlands of Ethiopia may offer 
enormous economic potential for the local people 
and the whole nation. However, this rich potential 
has not yet been exploited nor the vegetation 
resources received attention for sound 
management. Therefore, introduction of such 
industries may render the local people and the 
whole nation several incentives to protect, manage 
and develop the vegetation resources. This in turn 
will save the fragile arid and semi-arid lowlands 
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